DeveloperRegistry sponsors include Novo Nordisk A/S, Ascendis Pharma A/S, Dr. David Wasserstein. Sponsor identity does not establish product approval.
AliasesSomatropin, HGH, Human growth hormone, Recombinant human growth hormone
Biological targetsGrowth hormone activates its receptor and affects growth and metabolism, including IGF-I production. It differs from peptides that stimulate pituitary release.
Development stageRegistered intervention phases: Early Phase 1, Phase 1, Phase 1 / Phase 2, Phase 2, Phase 2 / Phase 3, Phase 3, Phase 4. See study-specific context.
Regulatory statusFDA-authorized somatropin products have defined labeling and warnings. A research vial described as HGH is not automatically equivalent to an approved prescription medicine.